Journal Article Summary
The article investigates the effects of the antipsychotic drug risperidone (RISP) on recovery following traumatic brain injury (TBI). Previous studies indicated that daily use of RISP could hinder recovery, making it essential to explore whether intermittent dosing would have a less negative impact. This research is particularly relevant as many TBI patients do not require constant medication for agitation, and understanding the optimal dosing strategy could improve rehabilitation outcomes.
In the study, researchers used adult male rats that underwent controlled cortical impact injuries or sham surgeries. The rats were divided into groups receiving different frequencies of RISP administration—once, three times, or seven times a week—alongside a control group receiving a vehicle solution. The findings revealed that the group receiving RISP daily experienced significant motor and cognitive impairments compared to those receiving it less frequently or the control group. This suggests that intermittent use of RISP does not impede spontaneous recovery after TBI, supporting the idea that less frequent dosing may be safer for patients.
However, the study has limitations, including its animal model, which may not fully replicate human responses to TBI and medication. Additionally, the research primarily focused on motor and cognitive outcomes without addressing other potential side effects of RISP. Patients and caregivers should discuss the use of antipsychotic medications like RISP with healthcare professionals, particularly regarding the frequency of administration and its implications for recovery after TBI.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Carlson Lauren J., Bao Gina C., Besagar Sonya, Leary Jacob B., Radabaugh Hannah L., Bondi Corina O., Kline Anthony E.. Spontaneous recovery after controlled cortical impact injury is not impeded by intermittent administration of the antipsychotic drug risperidone. Neuroscience letters 2018. DOI: 10.1016/j.neulet.2018.06.007. PMID: 29885446. PMCID: PMC6102063.
Featured Pill Pals Product
Risperidone 0.25 mg Tablets --- Generic For Risperdal --- Ajanta
Risperidone 0.25 mg Tablets — Generic For Risperdal — Ajanta is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
